Dan Shore

Chief Financial Officer at The Broad Institute, Inc.

Dan Shore

Dan Shore

Chief Financial Officer at The Broad Institute, Inc.

Overview
Career Highlights

The Broad Institute, Inc.

RelSci Relationships

203

Relationships
RelSci Relationships are individuals Dan Shore likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Eli & Edythe Broad Foundation

Relationship likelihood: Strong

President & Director at The Broad Institute, Inc.

Relationship likelihood: Strong

Executive Director, Center for the Science of Therapeutics at The Broad Institute, Inc.

Relationship likelihood: Strong

Director, Sponsored Research & Planning at The Broad Institute, Inc.

Relationship likelihood: Strong

Senior Director Genomics Platform at The Broad Institute, Inc.

Relationship likelihood: Strong

Director, Genomic Sequencing Center for Infectious Diseases at The Broad Institute, Inc.

Relationship likelihood: Strong

Director, Genome Sequencing & Analysis Program at The Broad Institute, Inc.

Relationship likelihood: Strong

Member, Editorial Board at CBE - Life Sciences Education

Relationship likelihood: Strong

Assistant Director at The Broad Institute, Inc.

Relationship likelihood: Strong

Former Chief Financial Officer at The Broad Institute, Inc.

Relationship likelihood: Strong

Paths to Dan Shore
Potential Connections via
Relationship Science
You
Dan Shore
Chief Financial Officer at The Broad Institute, Inc.
Career History
Chief Financial Officer
Current

The Broad Institute evolved from a decade of informal and successful research collaborations among scientists in the MIT and Harvard communities. In 1990, the Whitehead Institute/MIT Center for Genome Research (WICGR) was founded, and it soon became an international leader in the field of genomics and a flagship of the Human Genome Project. As early as 1995, WICGR scientists recognized the need to bring the power of genomics to the understanding of human disease. It launched pilot projects in genomic medicine, forming an unofficial collaborative network among scientists from across MIT and Harvard who pioneered new approaches to cancer and human genetics. In parallel, Harvard Medical School-based scientists established the Institute of Chemistry and Cell Biology (ICCB) in 1998, to facilitate the pursuit of chemical genetics as an academic discipline and a tool to further understand human biology and disease. In 2002, the ICCB was awarded an Initiative for Chemical Genetics (ICG) grant from the National Cancer Institute, and its successful Investigator-Initiated Screening Program facilitated small molecule screening projects for more than 80 research groups worldwide. These projects demonstrated the power of enabling scientists to collaborate to tackle the major challenges in molecular medicine. It was clear that a new type of formal organization was required — open, collaborative, interdisciplinary, and able to organize projects at any scale. In addition, it was important that the complementary expertise of the genomic scientists and the chemical biologists across MIT and Harvard be brought together in one place to drive the transformation of medicine with molecular knowledge. Discussions in 2002-2003 among Eli and Edythe Broad, MIT, Harvard and its affiliated hospitals, and the Whitehead Institute shaped the vision for this new institute. The extraordinary generosity of Eli and Edythe Broad, through their founding gift of $100 million (later doubled to $200 million) made it possible to formally announce the new institute in June 2003 and to launch it in May 2004. Less than four years after its launch, the Broads gave an unprecedented gift of $400 million in September 2008 to permanently endow the institute, providing long-term sustainability for its unique model of collaborative, inter-institutional research.

Other Affiliations

Dan Shore is affiliated with The Broad Institute, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Dan Shore. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Dan Shore's profile does not indicate a business or promotional relationship of any kind between RelSci and Dan Shore.